Correction to Lancet Respir Med 2018; 6: 545-53
- PMID: 30926052
- DOI: 10.1016/S2213-2600(19)30094-3
Correction to Lancet Respir Med 2018; 6: 545-53
Erratum for
-
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study.Lancet Respir Med. 2018 Jul;6(7):545-553. doi: 10.1016/S2213-2600(18)30202-9. Epub 2018 Jun 7. Lancet Respir Med. 2018. PMID: 29886024 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
